Your browser doesn't support javascript.
loading
BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study.
Rosa, Regis Goulart; Falavigna, Maicon; Manfio, Josélia Larger; de Araujo, Cintia Laura Pereira; Cohen, Mírian; do Valle Barbosa, Gynara Rezende Gonzalez; de Souza, Ana Paula; Romeiro Silva, Fernanda Kelly; Sganzerla, Daniel; da Silva, Mariana Motta Dias; Ferreira, Diogo; de Oliveira Rodrigues, Cristina; de Souza, Emanuel Maltempi; de Oliveira, Jaqueline Carvalho; Gradia, Daniela Fiori; Brandalize, Ana Paula Carneiro; Royer, Carla Adriane; Luiz, Rafael Messias; Kucharski, Gabriela Almeida; Pedrotti, Fernando; Valluri, Srinivas Rao; Srivastava, Amit; Julião, Viviane Wal; Melone, Olga Chameh; Allen, Kristen E; Kyaw, Moe H; Spinardi, Julia; Del Carmen Morales Castillo, Graciela; McLaughlin, John M.
Afiliação
  • Rosa RG; Internal Medicine Department, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil. Electronic address: regisgoulartrosa@gmail.com.
  • Falavigna M; Research Unit, Inova Medical, Porto Alegre, RS, Brazil; Research Institute, HMV, Porto Alegre, RS, Brazil; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Manfio JL; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil; Federal University of Rio Grande do Sul (UFRGS), Brazil.
  • do Valle Barbosa GRG; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • de Souza AP; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • Romeiro Silva FK; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • Sganzerla D; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • da Silva MMD; Research Institute, HMV, Porto Alegre, RS, Brazil.
  • Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil.
  • de Oliveira Rodrigues C; Faculty of Medicine - Campus Toledo - Federal University of Paraná (UFPR), Brazil.
  • de Souza EM; Department of Biochemistry and Molecular Biology, Department of Genetics - UFPR, Brazil.
  • de Oliveira JC; Department of Biochemistry and Molecular Biology, Department of Genetics - UFPR, Brazil.
  • Gradia DF; Department of Biochemistry and Molecular Biology, Department of Genetics - UFPR, Brazil.
  • Brandalize APC; Faculty of Medicine - Campus Toledo - Federal University of Paraná (UFPR), Brazil.
  • Royer CA; Department of Biochemistry and Molecular Biology, Department of Genetics - UFPR, Brazil.
  • Luiz RM; Faculty of Medicine - Campus Toledo - Federal University of Paraná (UFPR), Brazil.
  • Kucharski GA; Department of Health of Toledo, Toledo, PR, Brazil.
  • Pedrotti F; Department of Health of Toledo, Toledo, PR, Brazil.
  • Valluri SR; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA; Orbital Therapeutics, Cambridge, MA, USA.
  • Julião VW; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Melone OC; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Allen KE; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • Del Carmen Morales Castillo G; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
  • McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs - Emerging Markets, Collegeville, PA, USA.
Vaccine ; 41(37): 5461-5468, 2023 08 23.
Article em En | MEDLINE | ID: mdl-37507274
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Article